{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:14:52Z","timestamp":1792124092851,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"P-CREATE"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS KAKENHI","award":["17H03577"],"award-info":[{"award-number":["17H03577"]}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007533","name":"Kobayashi Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007533","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japanese Foundation For Cancer Research"},{"name":"Fujii Memorial Medical Science Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.canlet.2019.03.023","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T01:47:27Z","timestamp":1553132847000},"page":"178-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8\/A9 binding in the original skin lesion"],"prefix":"10.1016","volume":"452","author":[{"given":"Youyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Wayan","family":"Sumardika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahoko","family":"Tomonobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Made","family":"Winarsa Ruma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaku","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuta","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Shien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Futami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Sasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyoko","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endy Widya","family":"Putranto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Hibino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0566-4872","authenticated-orcid":false,"given":"Masakiyo","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.03.023_bib1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1253735","article-title":"The melanoma revolution: from UV carcinogenesis to a. new era in therapeutics","volume":"346","author":"Jennifer","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.canlet.2019.03.023_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.03.023_bib3","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2019.03.023_bib4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/ncb1794","article-title":"The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase","volume":"10","author":"Hiratsuka","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2019.03.023_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-013-2737-1","article-title":"RAGE-binding S100A8\/A9 promotes. the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition","volume":"142","author":"Yin","year":"2013","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.canlet.2019.03.023_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1158\/0008-5472.CAN-11-3843","article-title":"S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis","volume":"73","author":"Hibino","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.023_bib7","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.jid.2016.06.617","article-title":"Identification. of an S100A8 receptor neuroplastin-\u03b2 and its heterodimer formation with EMMPRIN","volume":"136","author":"Sakaguchi","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.canlet.2019.03.023_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10585-016-9801-2","article-title":"MCAM, as a. novel receptor for S100A8\/A9, mediates progression of malignant melanoma through prominent activation of NF-\u03baB and ROS formation upon ligand binding","volume":"33","author":"Ruma","year":"2016","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2019.03.023_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12033-014-9738-0","article-title":"Dramatic increase in expression of a transgene by insertion of promoters downstream of the cargo gene","volume":"56","author":"Sakaguchi","year":"2014","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.canlet.2019.03.023_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3727\/096504017X15031557924123","article-title":"\u00df-1,3-galactosyl-O-glycosyl-glycoprotein \u00df-1,6-N- acetylglucosaminyltransferase 3 increases MCAM stability, which enhances S100A8\/A9- mediated cancer motility","volume":"26","author":"Sumardika","year":"2017","journal-title":"Oncol. Res."},{"key":"10.1016\/j.canlet.2019.03.023_bib11","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jid.2016.05.116","article-title":"CD271 down-regulation promotes melanoma progression and invasion in three-dimensional models and in zebrafish","volume":"136","author":"Saltari","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.canlet.2019.03.023_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nature10005","article-title":"COP1 is a tumour. suppressor that causes degradation of ETS transcription factors","volume":"474","author":"Vitari","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.03.023_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature06024","article-title":"Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer","volume":"448","author":"Tomlins","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.03.023_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent. TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.canlet.2019.03.023_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cell.2015.06.023","article-title":"The Ras-Erk-ETS- signaling pathway is a drug target for longevity","volume":"162","author":"Slack","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.03.023_bib16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the. BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.03.023_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.03.023_bib18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/2159-8290.CD-16-0955","article-title":"Biomarker Accessible and chemically Addressable mechanistic subtypes of BRAF melanoma","volume":"7","author":"Eskiocak","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2019.03.023_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/path.4728","article-title":"Neuropilin-2 promotes. tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK-MAPK-ETV4-MMP-E-cadherin deregulation","volume":"239","author":"Fung","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2019.03.023_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/bjc.2011.187","article-title":"PEA3\/ETV4- related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma","volume":"105","author":"Keld","year":"2011","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2019.03.023_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/1476-4598-9-313","article-title":"The ERK MAP kinase- PEA3\/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma","volume":"9","author":"Keld","year":"2010","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2019.03.023_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","article-title":"Dermatologic Cooperative Oncology Group of Germany (DeCOG). The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2019.03.023_bib23","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1158\/1535-7163.MCT-16-0068","article-title":"The BRAF inhibitor vemurafenib activates mitochondrial metabolism and inhibits hyperpolarized pyruvate-lactate exchange in BRAF-mutant human melanoma cells","volume":"15","author":"Delgado-Goni","year":"2014","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.canlet.2019.03.023_bib24","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/0008-5472.CAN-15-1364","article-title":"MCAM and LAMA4 are highly enriched in tumor blood vessels of renal cell carcinoma and predict patient outcome","volume":"76","author":"Wragg","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.023_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/cr.2015.15","article-title":"CD146 acts as a novel receptor for. netrin-1 in promoting angiogenesis and vascular development","volume":"25","author":"Tu","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2019.03.023_bib26","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1084\/jem.20051848","article-title":"The BRAF-MAPK signalling. pathway is essential for cancer-immune evasion in human melanoma cells","volume":"203","author":"Sumimoto","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2019.03.023_bib27","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20160855","article-title":"An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition","volume":"214","author":"Young","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2019.03.023_bib28","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1128\/MCB.11.8.4088","article-title":"Structure and transforming potential of the human cot oncogene encoding a putative protein kinase","volume":"11","author":"Miyoshi","year":"1991","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2019.03.023_bib29","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1158\/1078-0432.CCR-13-3122","article-title":"BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact","volume":"20","author":"Rizos","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.023_bib30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nature09627","article-title":"COT drives resistance to RAF inhibition through MAP kinase pathway reactivation","volume":"468","author":"Johannessen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.03.023_bib31","article-title":"Effects of in utero exposure to ethinyl estradiol on tamoxifen resistance and breast cancer recurrence in a preclinical model","volume":"109","author":"Hilakivi-Clarke","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2019.03.023_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006451","article-title":"A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion","volume":"13","author":"Lema\u00eetre","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.canlet.2019.03.023_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ng.3728","article-title":"Inactivation of Capicua drives cancer metastasis","volume":"49","author":"Okimoto","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2019.03.023_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.cr.7290028","article-title":"Leukolysin\/MMP25\/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage","volume":"9","author":"Pei","year":"1999","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2019.03.023_bib35","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.ejmech.2011.03.033","article-title":"Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors","volume":"46","author":"Nuti","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2019.03.023_bib36","doi-asserted-by":"crossref","first-page":"21998","DOI":"10.1074\/jbc.M701737200","article-title":"MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.03.023_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-008-9129-8","article-title":"MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer","volume":"27","author":"Sohail","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2019.03.023_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351930179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351930179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T06:37:37Z","timestamp":1565159857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438351930179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":38,"alternative-id":["S030438351930179X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.03.023","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8\/A9 binding in the original skin lesion","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}